PAVmed Inc. (PAVM)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $2.64
- As of
Kresmion compiles this page from PAVM's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
PAVmed Inc. (PAVM): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-10.
See the full PAVM dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PAVM on one page. Preview it with sample data, then open it live with a free account.
Preview the PAVM dossierActive signals for PAVM
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 81.5%, EPS $-0.87 vs $-0.4794 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 458.1% - EPS $-22.2 vs $-3.978 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 67.2% - EPS $-8.7 vs $-5.202 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 519.0% - EPS $-4.42 vs $-0.714 estimate
- mediumEARNINGS_MISS
Missed consensus by 458.1% - EPS $-22.2 vs $-3.978 estimate
FREE, NO ACCOUNT
Every signal on PAVM, as it fires
You are seeing 5 of 7 signals recorded on PAVM since 2026-05-31.
The five above landed across 3 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, PAVM
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
PAVM against its peers
PAVM's operating margin of -30712.7% ranks in the 7th percentile of 21 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | PAVM | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 71000 USD | 10.6M USD | 15 | 22 |
| Gross margin | n/a | 56.4% | n/a | 22 |
| Operating margin | -30712.7% | -226.0% | 7 | 21 |
| Net margin | 564.8% | -222.2% | 98 | 23 |
| Return on equity | 1.2% | -126.8% | 89 | 22 |
| 1 year | -84.1% | -41.3% | 22 | 15 |
Peers (24): MODD, BDMD, RDGL, GTHP, PETV, FOFA, LFWD, NSPR, HSCS, ITOC, PMI, NSYS, ELUT, SINT, PLSM, ARAY, QTI, CVRX, NNOX, ALRTF, IRIX, CTSO, RPID, XTNT. Left out: TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (PAVM: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow PAVM on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to PAVM for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.